Effect of Position-Based Dosing Strategy for Metaraminol on Neonatal Acid-Base Status During Elective Caesarean Delivery: A Noninferiority Randomised Controlled Trial.

IF 4.7 2区 医学 Q1 CHEMISTRY, MEDICINAL
Drug Design, Development and Therapy Pub Date : 2024-12-20 eCollection Date: 2024-01-01 DOI:10.2147/DDDT.S492254
Tianyu Liu, Hua Jiang, Chao Xu, Lei Li, Hong Zhang, Yi Feng
{"title":"Effect of Position-Based Dosing Strategy for Metaraminol on Neonatal Acid-Base Status During Elective Caesarean Delivery: A Noninferiority Randomised Controlled Trial.","authors":"Tianyu Liu, Hua Jiang, Chao Xu, Lei Li, Hong Zhang, Yi Feng","doi":"10.2147/DDDT.S492254","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The 15° left tilt position during caesarean delivery has been recommended by guidelines for many years, but recent studies have questioned the clinical benefit of left tilt position. We hypothesize that using a higher starting dose of metaraminol in the supine position will result in a non-inferior umbilical arterial pH, compared to the 15° left tilt position.</p><p><strong>Methods: </strong>Healthy women undergoing elective caesarean delivery were randomized to the supine position (n = 62) or 15° left tilt position (n = 62) after spinal anaesthesia (0.5% bupivacaine 9 mg). Different starting doses of metaraminol infusion were initiated at 2.7 μg kg<sup>-1</sup> min<sup>-1</sup> for the supine position group and 2.0 μg kg<sup>-1</sup> min<sup>-1</sup> for the tilt position group. The infusion rates were then adjusted using a fixed algorithm to maintain systolic blood pressure. The primary outcome was the pH of the umbilical artery.</p><p><strong>Results: </strong>Compared with tilt group, pH (supine group: 7.325 (7.29, 7.35) vs tilt group: 7.33 (7.3, 7.35), P = 0.76) and base excess (tilt group: -0.98 (2.59) mM vs supine group: -0.92 (2.77) mM, P = 0.9) of the umbilical artery are non-inferior. There was no difference in SBP (P = 0.16) or incidence of hypotension (P = 0.75) between the two groups. The incidence of reactive hypertension was greater in the supine position group (P < 0.001).</p><p><strong>Conclusion: </strong>If maternal blood pressure is maintained using the higher starting dose of metaraminol, the left tilted position may not be necessary among healthy patients (BMI less than 35 kg/m<sup>2</sup>) undergoing elective caesarean delivery with spinal anaesthesia.</p>","PeriodicalId":11290,"journal":{"name":"Drug Design, Development and Therapy","volume":"18 ","pages":"6209-6219"},"PeriodicalIF":4.7000,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11668338/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Design, Development and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/DDDT.S492254","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The 15° left tilt position during caesarean delivery has been recommended by guidelines for many years, but recent studies have questioned the clinical benefit of left tilt position. We hypothesize that using a higher starting dose of metaraminol in the supine position will result in a non-inferior umbilical arterial pH, compared to the 15° left tilt position.

Methods: Healthy women undergoing elective caesarean delivery were randomized to the supine position (n = 62) or 15° left tilt position (n = 62) after spinal anaesthesia (0.5% bupivacaine 9 mg). Different starting doses of metaraminol infusion were initiated at 2.7 μg kg-1 min-1 for the supine position group and 2.0 μg kg-1 min-1 for the tilt position group. The infusion rates were then adjusted using a fixed algorithm to maintain systolic blood pressure. The primary outcome was the pH of the umbilical artery.

Results: Compared with tilt group, pH (supine group: 7.325 (7.29, 7.35) vs tilt group: 7.33 (7.3, 7.35), P = 0.76) and base excess (tilt group: -0.98 (2.59) mM vs supine group: -0.92 (2.77) mM, P = 0.9) of the umbilical artery are non-inferior. There was no difference in SBP (P = 0.16) or incidence of hypotension (P = 0.75) between the two groups. The incidence of reactive hypertension was greater in the supine position group (P < 0.001).

Conclusion: If maternal blood pressure is maintained using the higher starting dose of metaraminol, the left tilted position may not be necessary among healthy patients (BMI less than 35 kg/m2) undergoing elective caesarean delivery with spinal anaesthesia.

择期剖宫产时体位给药策略对新生儿酸碱状态的影响:一项非劣效性随机对照试验。
背景:剖宫产时左侧倾斜15°的体位多年来一直被指南推荐,但最近的研究对左侧倾斜体位的临床益处提出了质疑。我们假设,与15°左倾位相比,在仰卧位使用较高的起始剂量的甲氨醇将导致非下脐动脉pH。方法:择期剖宫产的健康妇女在脊髓麻醉(0.5%布比卡因9 mg)后随机分为仰卧位(n = 62)和左倾15°位(n = 62)。平卧位组和俯卧位组分别以2.7 μg kg-1 min-1和2.0 μg kg-1 min-1给药。然后使用固定算法调整输液速率以维持收缩压。主要结果是脐带动脉的pH值。结果:与倾斜组比较,脐动脉pH值(仰卧组:7.325 (7.29,7.35)vs倾斜组:7.33 (7.3,7.35),P = 0.76)和基底过量(倾斜组:-0.98 (2.59)mM vs仰卧组:-0.92 (2.77)mM, P = 0.9)非下位。两组患者收缩压(P = 0.16)和低血压发生率(P = 0.75)无差异。仰卧位组反应性高血压的发生率较高(P < 0.001)。结论:如果使用较高起始剂量的甲氨醇维持产妇血压,健康患者(BMI小于35 kg/m2)择期剖宫产脊髓麻醉时可能不需要左侧倾斜体位。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drug Design, Development and Therapy
Drug Design, Development and Therapy CHEMISTRY, MEDICINAL-PHARMACOLOGY & PHARMACY
CiteScore
9.00
自引率
0.00%
发文量
382
审稿时长
>12 weeks
期刊介绍: Drug Design, Development and Therapy is an international, peer-reviewed, open access journal that spans the spectrum of drug design, discovery and development through to clinical applications. The journal is characterized by the rapid reporting of high-quality original research, reviews, expert opinions, commentary and clinical studies in all therapeutic areas. Specific topics covered by the journal include: Drug target identification and validation Phenotypic screening and target deconvolution Biochemical analyses of drug targets and their pathways New methods or relevant applications in molecular/drug design and computer-aided drug discovery* Design, synthesis, and biological evaluation of novel biologically active compounds (including diagnostics or chemical probes) Structural or molecular biological studies elucidating molecular recognition processes Fragment-based drug discovery Pharmaceutical/red biotechnology Isolation, structural characterization, (bio)synthesis, bioengineering and pharmacological evaluation of natural products** Distribution, pharmacokinetics and metabolic transformations of drugs or biologically active compounds in drug development Drug delivery and formulation (design and characterization of dosage forms, release mechanisms and in vivo testing) Preclinical development studies Translational animal models Mechanisms of action and signalling pathways Toxicology Gene therapy, cell therapy and immunotherapy Personalized medicine and pharmacogenomics Clinical drug evaluation Patient safety and sustained use of medicines.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信